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C-13-alkylated methoxy-8tf-dibenzo[a,g]quinolizin-8-ones 2a-e were syn-
thesized by photocyclization of 1 -alkylidene-N-benzoyl-1,2,3,4-tetrahydro-
isoquinolines 1. Moreover, condensation of l,2,3,4-tetrahydro-6,7-dimeth-
oxy-l-oxo-isoquinoline with homophthalic acid anhydrides 7a and b leads to 
the C-13-alkylated 8-oxoberbines 2b and c and improves the yields com-
pared with those of the photocyclization method. 
Synthese von C-13-alkyIierten 8-Oxoberbinen 
Die C-13-alkyHerten Methoxy-8//-dibenzo[ö,^}chinolizin-8-one 2a-e wur-
den durch Photozyklisierung der l-Alkyliden-N-benzoyl-l,2,3,4-tetrahydro-
isochinoline 1 synthetisiert, aber auch die Kondensation von 1,2,3,4-Tetrahy-
dro-6,7-dimethoxy-l-oxo-isochinolin mit den Homophthalsäureanhydriden 
7a und b fuhrt zu den C-13-alkylierten 8-Oxoberbinen 2b und c und verbes-
sert die Ausbeuten, verglichen mit der Photozyklisierungsmethode. 
In connection with our investigations of compounds with cytostatic activ-
ity and affinity to steroid receptors we synthesized a number of 8-oxober-
bines1'2*. These compounds were prepared either according to Lenz3) or to 
Ninomiycfi by photocyclization or using Haimova's strategy5*. In this paper 
we describe the synthesis of C-J3-alkylated 8-oxoberbines, because the 
C-13-substituent was regarded as a lipophilic anchor for the estrogen recep-
tor. 
a) Photochemical synthesis of C-13-alkylated 8-oxoberbines 
C-13-alkyl-8-oxoberbines with one methoxy group in 
each aromatic ring were obtained only by photocyclization, 
because alkylated mono-methoxy homophthalic acid anhy-
drides, necessary according to method b) (see below), are 
accessible with difficulties only. This photocyclization starts 
with enamides, often used for the preparation of protober-
bines3,4). On account of the formation of a variety of pro-
ducts, quite often the reaction is not controllable because of 
the excess of energy used during photocyclization, resulting 
in poor yields and extensive purification. In spite of these 
handicaps C-13-alkylated 8-oxoberbines can be prepared 
rather easily by this method6* and so we synthesized com-
pounds 2a-e according to this procedure. 
l-Alkyl-3,4-dihydroisoquinolines 5 obtained via amides 4 
(Scheme 2) are condensed with benzoic acid chlorides 6 
affording 1 -alkylidene-N-benzoyl-1,2,3,4-tetrahydroisoqui-
nolines 1 which were cyclized to the 8-oxoberbines 2 which 
were subsequently converted to the acetoxy derivatives 3 
(Scheme 1). 
ß-(3-Methoxyphenyl)-ethylamine or homoveratrylamine 
was condensed base catalyzed with the appropriate acid 
chlorides to get compounds 4. The yields are nearly quanti-
tative and are higher than those of the condensation of these 
ß-phenylethylamines with the pertinent esters7*. 
Amides 4 are cyclized to the 1-alkyl substituted 3,4-dihy-
droisoquinolines 5 by Bischler-Napieralski reaction with 
POCI3 in acetonitrile (Scheme 2). The nitrilium ion - formed 
la : R 1 = R 2 = H, R 3 = CH3 1. [l,5]-sigmatropic 
lb : R 1 = R 2 = OCH3, R 3 * CH3 rearrangement 
lc : R 1 = R 2 = OCH3, R 3 = C2H5 2. Oxidation 
X = OCH 3 
(same skeleton as 2) 2)Ac20, II I 
pyridine 
3a : R 1 = R 2 = R 3 = OCOCH3, R 4 = H, R 5 = C 2 H 5 R « ^ V ^ R 2 
3b: R 1 = R 3 = R 4 = H, R 2 = OCOCH 3 f R 5 = CH3 £3 
3c: R 1 = R 3 = R 4 = H, R 2 = OCOGH3, R 5 = C2H5 
X = 0-CO-CH 3 
2a : R 1 = R 3 = R 4 = H, R 2 = OCH3, R 5 = C H 3 
2b:R 1 = R 2 = R 3 = OCH 3 ,R 4 = H, R 5 = C H 3 
2c:R 1 = R 2 = R 3 = OCH3,R 4 = H,R 5 = C 2 H5 
2d: R 1 = R 2 = R 3 = H, R 4 = OCH3, R 5 = CH3 
X = OCH 3 
Scheme 1: Photocyclization of the not brominated enamides la-c 
as an intermediate in this reaction - effects the ring closure 
with the C-atom of the aromatic ring. Use of acetonitrile 
favours cationic intermediates8* and therefore affords higher 
yields and less side products; the 3,4-dihydroisoquinolines 5 
were purified via their hydrochlorides, and are low melting 
solids. 
Besides the 8-oxoberbines 2a and 2d which were avail-
able only by this procedure, also compounds 2b, 2c, and 2e 
have been synthesized by cyclization of the pertinent 1-al-
kylidene-N-benzoyl-3,4-dihydroisoquinolinesl. 
For the synthesis of enamides 1 Lenz9) condensed the perti-
nent l-alkyl-3,4-dihydroisoquinolines with benzoic acid an-
hydrides, whilst Ninomiyal0) used more easily available ben-
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6a : R 1 = H, R 2 = Br 
6b: R 1 = R 2 = H 
6c: R 1 = OCH3, R 2 = H 
6d:R 1 = OCH 3 ,R 2 = Br 
a : R 1 = H ,R 2 = C H 3 
b : R ' = H,R 2 = C 2 H 5 
d : R = OCH 3 , R = C2H5 
zoic acid chlorides. Therefore, we also started from benzoic 
acid chlorides which were condensed base catalyzed in ben-
zene with compounds 5 affording the 1 -alkylidene-N-ben-
zoyl-3,4-dihydroisoquinolines 1 (Scheme 2). The benzenic 
solution of the product can be used directly for photocycliza-
tion after separation from triethylamine hydrochloride. 
The E- and Z-isomers of the enamides 1 arose in different ratios, but in 
some cases the Z-isomer came up only. Ninomiyal0) explained analogous 
findings by the different bulkiness of the N-aroyl groups, but also the aro-
matic protons of the isoquinoline ring system influence the ratio of the iso-
mers1 l ) : C-8-H in ring A of the isoquinoline overlaps according to the Van der 
Waals~T2&\\ in DraV/mg-models with the alkyl substituent, and so the forma-
tion of the Z-isomer is preferred on account of sterical hindrance (Fig. 1). 
H 3CO-£-
0CH3 
E - Isomer 
Fig.l 12) 
These considerations, however, can not fully explain our 
observations: 
1) The C-3'-OCH3-singlet is shifted upfield in the Z-isomer 
for 0.2-0.3 ppm, as compared with the £-isomer: when 
the aroyl rest is rotating around the N-CO-bond the 
methoxy group is influenced by the alkylidene moiety. 
2) Rotation of the aroyl rest around this N-CO-bond leads 
to broad signals in the 250-MHz-spectra; at -50°C, how-
ever, the molecules are "frozen" and well resolved sig-
nals can be seen (Fig. 2). 
3) In 1-ethylidene derivatives, not brominated in the aroyl 
ring system (la, e.g. - Scheme 1), only the Z-isomer 
arises because of the interaction described above (Fig. 
1). If, however, the aroyl ring system contains bromine 
(Id, e.g. - Scheme 3) also the ^-isomer is formed on 
account of the rotation of the C-2'-brominated aroyl in-
crement (mono-methoxy substitution: E/Z = 1:1; di-
methoxy substitution: E/Z = 3:7). 
4) In 1-propylidene substituted isoquinolines (lc or le, 
e.g.), independent of the bromine substitution at the 
aroyl ring system, only the Z-isomer is formed; the steri-
cal interaction of the propylidene group with the aro-
matic C-8-H is stronger than the sterical hindrance by 
the substituents of the benzoyl group so preventing the 
formation of the £-isomer. 
Compound lc/Z-isomer (Fig. 2) exhibits the triplet of the propylidene 
group at 5 = 0.72 ppm, the pertinent methylene group resonates as a multi-
plet at 8 = 2.02 ppm. One C-3-H leads to a broad signal at 5 = 2.82 ppm. 
The protons of the C-4-methylene group also show a multiplet in the 250-
MHz-spectrum at -50°C at 8 = 3.22 ppm. As described above the C-3'-
methoxy group is shifted upfield, while the other methoxy groups form 
singlets near 8 = 3.95 ppm. The second C-3-H, extremely shifted down-
field, resonates as a multiplet at 8 = 5.11 ppm. This effect can be explained 
by the anisotropic effect of the carbonyl group6). By this chemical shift the 
signals of the different isomers can be assigned (Fig. 1): In the Z-isomer of 
e.g. Id the methyl-doublet (8 = 1.53 ppm) is shifted upfield as compared to 
the £-isomer (8 = 1.92 ppm) because of this interaction, while the quartet 
of the vinylic proton is shifted downfield (Z-isomen 8 = 6.23 ppm, E-
isomen 8 = 5.71 ppm).- The signals of the aromatic protons in Z-lc come 
up between 8 = 6.6 ppm and 7.2 ppm (Fig. 2). 
Oppm(S) 
. 2: H-NMR-spectra (250 MHz), compound lc (Z-isomer), at 24°C (below) and at -50°C (above) 
The mechanisms of the photocyclizations of the enamides, 
either brominated or not brominated, have been discussed 
by Len2?'9) or Ninomiya4'l0\ respectively. We used the oxi-
dative photocyclization of enamides 1, not substituted in the 
orf/w-position, for the preparation of compounds 2a-d. On 
account of the rotation around the N-CO-bond of the 3-
methoxy-benzoyl-enamide la we got 3,10- and 3,12-di-
methoxy-8-oxoberbines 2a and 2d as regioisomers. The te-
tramethoxy derivatives lb or lc did not show this effect. 
Because the yields in the dimethoxy derivatives 2a and 2d 
were low on account of the regioisomers mentioned above 
we switched from this oxidative photocyclization to the 
"refined" methods of Ninomiyal0) or Lenz9) making use of 
tfrf/jobrominated benzoyl increments in the enamides ld-f 
(Scheme 3). Here elimination of the ortho-group by irradia-
tion takes place. 
Id: R1 = R3 = H, R2 = OCH3, R4 = CH 3 2a: R1 = R3 = H, R2 = OCHr R4 = CH 3 
le: R1 * R3 m H, R2 = OCH3, R4 = C 2 H 5 2b:R1 = R2 = R3 = OCH3, R = CH 3 
If: R1 = R2 = R3 ss OCH3, R4 = CH 3 2e : R1 = R3 = H, R2 = OCH3, R4 = C2H5 
Scheme 3: Photocyclization of the brominated enamides ld-f 
b) Synthesis of C-13-alkylated 8-oxoberbines by conden-
sation ofl ,2,3,4-tetrahydro-l-oxo-isoquinolines with 
C-4-alkylated homophthalic acid anhydrides 
Haimova used this condensation for the synthesis of 
2,3,10,1 l-tetramethoxy-8-oxoberbine 5 ) . It had to be shown 
whether C-4-alkylated homophthalic acid anhydrides 7 
could also be used for this strategy (Scheme 4). We syn-
thesized the tetramethoxy-8-oxoberbines 2b and 2c by this 
method. As C-4-alkylated 6-mono-methoxy-substituted ho-
mophthalic acid anhydrides are not easily available, 8-oxo-
berbines with C-l 1-mono-mzthoxy substitution in ring D 
were not prepared by this route. 
" ^ V ^ l ^ l ° y ° Y 0 poc, 
0 Y ^ O C H 3 
OCH 3 
7a:R*CH 3 
Compounds 7 were synthesized via the dimethoxylactones 
10a and 10b. First the alkylated dimethoxyphenylacetoni-
triles 8a12) and 8b are hydrolysed to the phenylacetic acid 
derivatives 9a and 9b (Scheme 5). According to Finkelstein 
and Brossil3) the methylene group ortho to the acetic acid in-
crement was introduced into compounds 9 affording the lac-
tones 10, which are transformed by alkaline oxidation with 
KMnC>4 to the corresponding homophthalic acids. Under 
these conditions the alkyl groups are not oxidized. Ring clo-
sure to the homophthalic acid anhydrides 7 was effected by 
refluxing the acids with acetyl chloride (Scheme 5). 
a:R = CH 3 
b:R = C 2 H 5 
Scheme 5 
This extension of Haimova*s strategy5) simplifies known 
methods, including photocyclization, for the preparation of 
C-13-alkylated 8-oxoberbines, improves the yields and, 
probably, the total synthesis of alkaloids with a berbine 
skeleton. Pharmacological tests are described in a forthcom-
ing publication2*. 
Experimental Part 
Melting points: Büchi 510 apparatus, uncorrected.- Elemental analyses: 
Mikroanalytisches Laboratorium, University of Regensburg.- IR-spectra: 
Beckman Acculab III; KBr.- ^-NMR-spectra: Varian E M 390 (90 MHz), 
Bruker WM 250 (250 MHz); TMS as internal standard.- UV-spectra: Uvi-
kon 810 (Kontron); solvent: acetonitrile.- Mass-spectra: Varian MAT CH 5. 
N-Benzoyl-123,4-tetrahydroisoquinolines la-f, general procedure 
20 mmole of the acid chloride 6 in benzene (25 ml) are added to 2.2 g of 
triethylamine and 20 mmole of the 3,4-dihydroisoquinoline 5 in benzene 
(50 ml), then the solution is refluxed for 2 h. The precipitate is separated, 
the product in the remaining benzenic solution is used without purification.-
Purified for identification by CC (SiO* CHCyether 1:1 or EtOAc).-
Yields: 60-75% and small amounts of benzamide-derivatives. 
1 -Ethylidene-12 J ,4'tetrahydro-6-methoxy-2-(3-methoxybenzoyl)iso-
quinoline (la) 
Prepared from 5a and 6b6). 
2-(3 A-D\methoxybenzoyl)~l~ethylidene-l 2 J ,4-tetrahydrO'6J-dimeth-
oxy-isoquinoline (lb) 
From 5c and 6c; colorless crystals, m.p. 156-158°C (ether).- Z-isomer: 
C22H25NO5 (383.4) Calc. C 68.5 H 6.47 N 3.6 Found C 68.9 H 6.57 N 3.7.-
IR (KBr): 1625 (CO) cm*1.- ! H-NMR (250 MHz, -50°C, CDC13): 8 (ppm) = 
1.30 (d; J = 7 Hz; 3H; CH 3), 2.60-3.33 (m; 3H; CH 2 ; H-3/H-4), 3.76 (s; 3H, 
OCH3); 3.91, 3.93, 3.94 (s; 9H, OCH 3), 5.11 (m; 1H; H-3), 5.68 (q; J = 7 
Hz; 1H vinyl), 6.60-7.22 (m; 5H arom.). 
N-[^-(3,4-Dimethoxy-6-[l-oxopropyl]phenyl)ethyl]-3,4-dimethoxy-
benzamide 
Isolation by CC (Si0 2, EtOAc).- m.p. 128-130°C (ether).- C22H 2 7N0 6 
(401.4) .- IR (KBr): 3300 (NH), 1690 (CO), 1640 (CO-NH) cm 1 .- UV 
(MeOH): X max (log e) = 290 (4.02), 260 (4.25), 205 nm (4.64); no change 
by addition of HCl.- MS: m/z = 401 (5%, M*1"), 383 (4, (M - H20)\ 372 
(1), 220 (24), 191 (16), 165 (23), 43 (100). 
This compound has probably come up by hydrolysis of the pertinent 
3,4-dihydroisoquinoline derivative of lb. 
12 3 A"Tetrahydro-67-dimethoxy-2-(3,4-dimethoxybenzoyl)-l -propyl-
idene-isoquinoline (lc) 
From 5d and 6c; colorless crystals; m.p. 134-136°C (ether).- Z-isomen 
C23H27NO5 (397.5) Calc. C 69.5 H 6.65 N 3.5 Found C 69.5 H 6.85 N 3.5.-
IR (KBr): 1625 (CO) cm"1.- ! H-NMR (CDC13): 8 (ppm) = 0.72 (t; J = 7 Hz; 
3H, CH 3), 2.02 (m; 2H; CH2-CH3), 2.82 (m; 1H; H-3), 3.22 (m; 2H; C H 2 ; 
H-4), 3.76, 3.91, 3.94, 3.95 (s; 12 H; -OCH3), 5.11 (m; 1H; H-3), 5.52 (m; 
1H vinyl), 6.60-7.20 (m; 5H arom.). 
N-[$-(3,4-Dimethoxy-6-[l-oxobutyl]phenyl)ethyl]-3,4-dimethoxybenz-
amide* 
Isolation by CC (Si0 2, EtOAc), m.p. 128-130°C (ether).- C23H29N06 
(415.5) Calc. C 66.5 H 7.04 N 3.4 Found C 66.3 H 6.79 N 3.3.- IR (KBr): 
3300 (NH), 1690 (CO), 1640 (CO-NH) cm'1.- ! H-NMR (CDC13): 8 (ppm) 
= 1.00 (t; J = 7.5 Hz; 3H; CH 3), 1.57-1.90 (m; 2H; CH2-CH2-CH3), 2.77-
3.10 (m; 4H; CH2-CH2-CH3 and CH2-CH2-N), 3.57-3.85 (m; 2H; Qfc-N), 
3.9Ö (s; 12 H; OCH 3), 6.73-6.92 (m; 2H arom.), 7.10 (s; 1H arom.), 7.30-
7.50 (m; 2H arom.), 7.83 (s [broad]; 1H; NH).- UV (MeOH): X max (log e) 
= 292 (4.03), 260 (4.25), 210 nm (4.58); no change by addition of HC1.-
MS: m/z = 415 (3%, M+"), 397 (3, (M - H20)+*), 368 (1), 234 (96), 191 
(52), 179 (30), 165 (100), 137 (12). 
*) This compound has probably come up by hydrolysis of the pertinent 
3,4-dihydroisquinoline derivative of lc. 
2-(2-Bromo-5-methoxybenzoyl)-l-ethylidene-l ,2J ,4-tetrahydro-
6-methoxyisoquinoline (Id) 
From 5a and 6a; colorless crystals, m.p. 150-152°C (ether).- l:l-mixture 
of £/Z-isomers.- C2oH2oBrN03 (402.3) Calc. C 59.7 H 4.99 N 3.5 Found C 
59.7 H 5.01 N 3.5.- IR (KBr): 1635, 1640 (CO) cm"1.- Z-isomen ! H-NMR 
(CDCI3): 8 (ppm) = 1.53 (d; J = 7 Hz; 3H; CH 3), 2.71-2.97 (m; 3H; CH 2 ; 
H-3/H-4), 3.54, 3.80 (s; 6H, OCH 3), 4.99-5.11 (m; 1H; H-3), 6.23 (q; J = 7 
Hz; 1H vinyl), 6.25-6.88, 7.27-7.58 (m; 6H arom.).- E-isomen J H-NMR 
(CDCI3): 8 (ppm) = 1.92 (d; J = 7 Hz; 3H; CH 3), 3.14-3.40 (m; 2H; CH 2 ; 
H-4), 3.65 (s [broad]; 2H; CH 2 ; H-3), 3.80,3.81 (s; 6H; OCH 3), 5.71 (q; J = 
7 Hz; 1H vinyl), 6.25-6.88,7.27-7.58 (m; 6H arom.). 
2-(2-Bromo-5-methoxybenzoyl)-l 23,4-tetrahydro-6-methoxy-l -propyl-
idene-isoquinoline (le) 
From 5b and 6a; colorless crystals, m.p. 54-56°C (ether).- C2iH 22BrN0 3 
(416.3).- Z-isomer.- IR (KBr): 1640 (CO) cm"1.- !H-NMR (CDC13): 8 
(ppm) = 0.97 (t; J = 7.5 Hz; 3H; CH 3), 1.73 (m; 2H; CH2-CH3), 2.87 (t; J = 
6 Hz; 2H; CH 2 ; H-4), 3.13 (U J = 6 Hz; 2H; C H 2 ; H-3), 3.77 (s; 3H; 




From 5c and 6d; colorless crystals, m.p. 190-192°C (ether).-
C22H24BrN05 (462.3).- 3:7-mixture of £/Z-isomers.- IR (KBr): 1640 (CO) 
cm'1.- Z-isomer: !H-NMR (CDC13): 8 (ppm) = 1.56 (d; J = 7.5 Hz; 3H; 
CH 3), 2.62-3.36 (m; 3H; CH 2 ; H-3/H-4), 3.56 (s; 3H; OCH 3), 3.88 (s; 9H; 
OCH3), 5.09 (s [broad]; 1H, H-3), 6.38 (q; J = 7.5 Hz; 1H vinyl), 6.40-7.25 
(m; 4H arom.).- £-isomer. ! H-NMR (CDCl 3): 8 (ppm) = 1.96 (d; J = 7.5 Hz; 
3H; CH 3), 2.62-3.36 (m; 2H; CH 2 ; H-4), 3.56 (s [broad]; 2H; CH 2 ; H-3), 
3.88 (s; 3H; OCH 3), 3.91 (s; 9H; OCH 3), 5.75 (q; J = 7.5 Hz; 1H vinyl), 
6.40-7.25 (m;4Harom.). 
General Procedure for the Photocyclization 
The benzenic solution of the enamide 1 is degassed with N 2 in a prep-
arative photoreactor for 15 min. Then the solution is irradiated with a 125 
W Hg vapor lamp for 20-40 h and evaporated. The remaining oil is purified 
by CC (Si0 2, EtOAc or EtOAc/ether), yields 20-40%. 
5,6-Dihydro-3J0-dimethoxy-13-methyl-8H-dibenzo[atg]quinolizin-8-one 
(2a) 
From la or Id; colorless crystals, m.p. 178-180°C (EtOH).- C 2oH 1 9N03 x 
1/2 EtOH (344.4) Calc. C 73.2 H 6.44 N 4.1 Found C 73.2 H 6.31 N 4.1.-
IR (KBr): 1640 (CO) cm"1.- *H-NMR (CDC13): 8 (ppm) = 2.52 (s; 3H; 
CH 3), 2.82 (t; J = 6 Hz; 2H; C H 2 ; H-5), 3.82 (s; 3H; OCH 3), 3.93 (s; 3H; 
OCH3), 4.27 (t; J = 6 Hz; 2H; C H 2 ; H-6), 6.68-6.92 (m; 2H arom.), 7.20-
7.73 (m; 3H arom.), 7.88 (d; J = 2.5 Hz; 1H arom; H-9).- UV: X max (log £) 
= 314 (4.22), 255 (4.13), 213 nm (4.22). 
5,6-Dihydro-23,10,ll-tetramethoxy-13-methyl-8H-dibenzo[a,g]quinolizin-
8-one (2b) 
a) From lb or If by photocyclization. 
b) By condensation of l,2,3,4-tetrahydro-6,7-dimethoxy-l-oxo-isoqui-
noline14) with 6,7-dimeuwxy-4-memyl-isochromane-l,3-dione (7a) (cf15'1*).-
Light-brown crystals, m.p. 210-212°C (EtOH), lit 213-215°C9).- MS: m/z = 




a) From lc by photocyclization. 
b) By condensation of 1,2,3,4-tetrahydro-6,7-dimethoxy-1 -oxo-isoqui-
noline14) with 6,7-dimethoxy-4-ethyl-isochromane-l,3-dione (7b) (cf. 1 5 , 1 )).-
Yellow needles, m.p. 197-198°C (EtOH).- C23H25NO5 x 1/2 EtOH (418.5) 
Calc. C 68.9 H 6.74 N 3.4 Found C 69.2 H 6.74 N 3.2.- IR (KBr): 1635 
(CO) cm"1.- ! H-NMR (CDC13): 8 (ppm) = 1.55 (t; J = 7.5 Hz; 3H; CH 3), 
2.82 (t; J = 6 Hz; 2H; C H 2 ; H-5), 3.08 (q; J = 7.5 Hz; 2H; CH2-CH3), 3.97 
(s; 6H; OCH3), 4.08 (s; 6H; OCH3), 4.28 (U J = 6 Hz; 2H; CH2; H-6), 6.83, 
7.20,7.27,7.97 (s; 4H arom.).- UV: X max (log e) = 330 (4.39), 258 (4.45), 
229 nm (4.58).- MS: m/z = 395 (100%, M + ), 380 (50, *365.57, (M -
CH 3) +), 349 (51, *320.53, (380 - O C H 3 A 334 (19, *319.64, (349 - CHi)\ 
306 (5), 197.5 (7, M 2 + ) . 
5,6-Dihydro-3J2-dimethoxy-13-methyl-8H-dibenzo[a,g]quinolizin-8-one 
(2d) 
From la; colorless crystals, m.p. 177-179°C (EtOH).- C20H19NO3 x 1/2 
EtOH (344.4) Calc. C 73.2 H 6.44 N 4.1 Found C 73.5 H 6.48 N 4.O.- IR 
(KBr): 1640 (CO) cm'1.- ! H-NMR (CDC13): 8 (ppm) = 2.70 (s; 3H; CH 3), 
2.85 (t; J = 6 Hz; 2H; C H 2 ; H-5), 3.87 (s; 3H; OCH 3), 3.97 (s; 3H; OCH 3), 
4.27 (t; J = 6 Hz; 2H; C H 2 ; H-6), 6.72-6.97 (m; 2H arom.), 7.02-7.70 (m; 
3H arom.), 8.20 (dd; J 1 / 2 = 7.5 Hz/1.5 Hz; 1H arom; H-9).- UV: X max (log 
e) = 359 (4.26); 328 (4.20); 254 nm (4.20).- MS: m/z = 322 (24%, M+"), 321 
(49, *320.00, (M - H)+), 306 (41), 220 (27), 215 (76), 205 (93), 135 (100). 
13-Ethyl-5,6-dihydro-3J0-dimethoxy-8H-dibenzo[a,g]quinolizin-8-one(2e) 
From le; yellow foam, m.p. 130-131°C (EtOH).- C 2 i H 2 i N 0 3 (335.4) 
Calc. C 75.2 H 6.31 N 4.2 Found C 74.4 H 6.30 N 4.1.- IR (KBr): 1640 
(CO) cm"1.- ^ - N M R (CDC13): 8 (ppm) = 1.42 (t; J = 7.5 Hz; 3H; CH 3), 
2.80 (t; J = 6 Hz; 2H; CH 2 ; H-5), 2.98 (q; J = 7.5 Hz; 2H; CH2-CH3), 3.82 
(s; 3H; OCH 3), 3.93 (s; 3H; OCH 3), 4.23 (t; J = 6 Hz; 2H; C H 2 ; H-6), 
6.73-6.98 (m; 2H arom.), 7.20-7.83 (m; 3H arom.), 7.93 (d; J = 2.5 Hz; 1H 
arom; H-9).- UV: X max (log £) = 322 (4.23), 216 nm (4.54). 
2 3,10,11 -Tetraacetoxy-13-ethyl-5,6-dihydro-8H-dibenzo[a,g]quinolizin-
8-one (3a) 
From 2c according to lit.1*; m.p. 225-227°C (MeOH).- C27H25NO9 x 1 
H 2 0 (525.5) Calc. C 61,7 H 5.18 N 2.7 Found C 61.4 H 5.00 N 2.7.- IR 
(KBr): 1780,1770(CO-CH3), 1650 (CO) cm"1.- !H-NMR (CDC13): 8 (ppm) 
= 1.43 (t; J = 7.5 Hz; 3H; CH 3 ), 2.33 (s; 12 H; H3C-CO), 2.75-3.13 (m; 4H; 
CH2-CH3 and CH2/H-5), 4.28 (t; J = 6 Hz; 2H; CH 2 ; H-6), 7.20,7.53,7.70, 
8.38 (s; 4H arom.).- UV: X max (log e) = 330 (4.30), 213 nm (4.52). 
3,10-Diacetoxy-5,6-dihydro-13-methyl-8H-dibenzo[a,g]quinolizin-8-one 
(3b) 
From 2a according to lit.1*; m.p. 232-234°C (EtOH).- C22H 1 9N0 5 
(378.4) Calc. C 70.0 H 5.07 N 3.7 Found C 69.9 H 5.07 N 3.1.- IR (KBr): 
1760 (CO-CH3), 1650 (CO) cm"1.- *H-NMR (250 MHz, CDC13): 3 (ppm) = 
2.34 (s; 3H; H3C-CO), 2.36 (s; 3H; H3C-CO), 2.59 (s; 3H; CH 3), 2.93 (t; J 
= 6 Hz; 2H; C H 2 ; H-5), 4.28 (t; J = 6 Hz; 2H; CH 2 ; H-6), 7.07-7.11 (m; 2H 
arom.), 7.48 (dd; J 1 / 2 = 9/2.5 Hz; 1H arom.), 7.60 (d; J = 9 Hz; 1H arom.), 
7.81 (d; J = 9 Hz; 1H arom.), 8.21 (d; J = 2.5 Hz; 1H arom.; H-9).- UV: X 
max (log e) = 328 (4.22), 211 nm (4.53). 
3,10-Diacetoxy-13-ethyl-5,6-dihydro-8H-dibenzo[a,g]quinolizin-8-ow 
From 2e according to lit.1*; m.p. 195-197°C (MeOH).- C23H21NO5 x 1 
H 2 0 (409.5) Calc. C 67.5 H 5.66 N 3.4 Found C 67.9 H 5.88 N 3.5.- IR 
(KBr): 1760 (CO-CH3), 1640 (CO) cm*1.- ! H-NMR (250 MHz, CDC13): 8 
(ppm) = 1.47 (t; J = 7.5 Hz; 3H; -CH 3), 2.35 (s; 3H; H 3C-CO), 2.36 (s; 3H; 
H3C-CO), 2.88 (t; J = 7.5 Hz; 2H; CH 2 ; H-5), 3.03 (q; J = 7.5 Hz; 2H; 
CH2-CH3), 4.28 (s [broad]; 2H; CH 2 ; H-6), 7.12-7.17 (m; 2H arom.), 7.47 
(dd; J 1 / 2 = 9/2.5 Hz; 1H arom.), 7.66 (d; J = 9 Hz; 1H arom.), 7.85 (d; J = 9 
Hz; 1H arom.), 8.22 (d; J = 2.5 Hz; 1H arom.; H-9).- UV: X max (log e) = 
327 (4.25), 210 nm (4.57). 
Methoxyphenylethylamides 4a-d, general procedure 
100 mmole of propionic or butyric acid chloride are added under reflux 
to 100 mmole ß-(3-methoxyphenyl)ethylamine or homoveratrylamine and 
10.0 g triethylamine in 60 ml absol. CH 2C1 2. The mixture is stirred for 1 h, 
the precipitate is dissolved with 2N HCl and stirred again. The org. layer is 
separated, dried (Na2S04) and evaporated. The resulting pure methoxyphe-
nylethylamides 4 are cyclized without purification.- Yields quantitative. 
N~[$~(3-Methoxyphenyl)ethyl]propanamide(42L) 
From l-amino-2-(3-methoxyphenyl)ethane (Aldrich) and propionic acid 
chloride; colorless oil, b.p. 96-97°C, 0.05 T., lit. 97°C, 0.05f5*. 
N-[$-(3-Methoxyphenyl)ethyl]butanamide(4b) 
From l-amino-2-(3-methoxyphenyl)ethane (Aldrich) und butyric acid 
chloride; colorless oil, b.p. 185-187°C, 0.1 T.- IR (KBr): 3290 (NH), 1650 
(CO) cm*1.- ! H-NMR (CDC13): 8 (ppm) = 0.90 (t; J = 7.5 Hz; 3H; CH 3), 
1.37-1.82 (m; 2H; CH2-CH2-CH3), 2.10 (t; J = 7.5 Hz; 2H; CH2-CH2-CH3), 
2.77 (t; J = 7.5 Hz; 2H; CH2-CH2-NH-), 3.62 (q; J = 7.5 Hz; 2H; CH 2 -CHr 
N ; t after D-exchange), 3.73 (s; 3H; OCH 3), 6.22 (s [broad]; 1H; NH), 
6.57-6.87 (m; 3H arom.), 7.07-7.33 (m; 1H arom.). 
N-[$-(3,4-Dimethoxyphenyl )ethylJpropanamide (4c) 
From homoveratrylamine and propionic acid chloride; colorless crystals, 
m.p. 54-55°C (ether), lit.: 57.5-59°C1 6 ). 
N-[$-(3,4~Dimethoxyphenyl)ethyl]butanamide (4d) 
From homoveratrylamine and butyric acid chloride; colorless crystals, 
m.p. 49-50°C (ether), l i t : 51-53°C1 6 ). 
1 -Alkyl-3,4-dihydroisoquinolines 5a-d, general procedure 
100 mmole of amide 4 are dissolved in 120 ml acetonitrile p.a. and 
refluxed with 35 ml of POCl 3 for 3 h. Then excess of POCI3 and acetoni-
trile is distilled off and the remaining 3,4-dihydroisoquinoline hydro-
chloride is filtrated and dissolved in water. The solution is basified with 2N 
NaOH and extracted with 3 x 100 ml ether. The org. layers are dried 
(Na2S04) and evaporated: low melting solids or colorless to light-yellow 
oils.- Purification by Kugelrohr distillation.- Yields 55-70%. 
/ -Ethyl-3t4-dihydro-6-methoxy-isoquinoline (5a) 
From 4a; yellow crystals, m.p. 32°C, b.p. 133-135°C, 0.01 T, lit b.p. 
135°C, 0.01 T**. 
3,4-Dihydro-6-methoxy-l-propyl-isoquinoline(5b) 
From 4b; colorless oil, b.p.. 160-162°C, 0.1 T.- C 1 3 H 1 7 N O (203.3) Calc. 
C 76.8 H 8.43 N 6.9 Found C 76.5 H 8.22 N 6.8.- IR (KBr): 1625; 1610; 
1570; 1505 cm"1.- ! H-NMR (CDC13): 8 (ppm) = 0.95 (t; J « 7.5 Hz; 3H; 
CH 3), 1.47-1.85 (m; 2H; CH2-CH2-CH3), 2.60 (t [broad]; J = 7.5 Hz; 4H; 
CH2-CH 2-CH 3 and CHrCH 2 -N), 3.62 (t; J = 7.5 Hz; 2H; CHj-QJb-N), 
3.80 (s; 3H; OCH 3), 6.60-6.83 (m; 2H arom.), 7.42 (d; J » 7.5 Hz; 1H 
arom.).- UV: X max (log e) = 274 (3.73), 249 (3.70), 229 nm (3.58).- UV 
(plus HCl): X max Gog e) = 316 (3.81), 307 (3.81), 236 nm (3.70). 
1 -Ethyl-3,4-dihydro-6,7-dimethoxy-isoquinoline (5c) 
From 4c; yellow crystals, m.p. 45°C, lit. b.p. 127-130°C, 0.3 mm16*.-
C 1 3 H 1 7 N02 (219.3) Calc. C 71.2 H 7.81 N 6.4 Found C 70.9 H 7.87 N 6.2. 
3,4-Dihydro-6,7-dimethoxy1-propyl-isoquinoline (5d) 
From 4d; yellow crystals, m.p. 37°C, lit. b.p. 150-170°C, 2-3 mm16*.-
C 1 4 H 1 9 N 0 2 (233.3) Calc. C 72.1 H 8.21 N 6.0 Found C 71.9 H 8.29 N 
5.9. 
Acid chlorides 6a-d, general procedure 
200 mmole (brominated) methoxybenzoic acid are suspended in 50 ml of 
absol. CH 2C1 2 and 5 drops of DMF. 22 ml of SOCl 2 are added under 
stirring, then the mixture is refluxed for 2 h. Solvent and excess of reagent 
are distilled off. The resulting acid chlorides are purified by distillation or 
used without purification.- Yields 80-90%. 
2-Bromo-5-methoxy-benzoic acid chloride (6a) 
From 2-bromo-5-methoxy benzoic acid1*, yellow liquid, b.p. 105-107°C, 
0.1 T. 
m-Anisic acid chloride (6b) 
From m-anisic acid, yellow liquid, b.p. 94-95°C, 0.1 T.; lit. b.p. 242-
243°C, 733 mm17*. 
3,4-Dimethoxy-benzoic acid chloride (6c) 
From 3,4-dimethoxy benzoic acid (Merck); light-red precipitate, m.p. 65-
66°C; lit 70°C 1 8 ). 
2-Bromo-4J-dimethoxy-benzoic acid chloride (6d) 
From 2-bromo-4,5-dimethoxy benzoic acid 0, light-brown precipitate, 
m.p. 73-75°C. 
6,7-Dimethoxy-4-methyl-isochroman-lJ-dione{la) 
From 10a via 4,5-dimethoxy-a-methyl-homophthalic acid 1 5 ), which was 
heated with a^COCl 1 *. 
4 -Ethyl-6,7-dimethoxy-isochroman -1 J-dione (7b) 
From 10b via 4,5-dimethoxy-a-ethyl-homophthalic acid 1 5 ), which was 
heated with CH3COCI0. 
6,7~Dimethoxy-4-methyl-isochroman-3-one (10a) 
From 9a; colorless crystals, m.p. 122-124°C (EtOH).- C 1 2 H 1 4 0 4 (222.2) 
Calc. C 64.8 H 6.35 Found C 64.6 H 6.43.- IR (KBr): 1740 (CO) cm 1 .-
*H-NMR (CDCI3): 8 (ppm) = 1.67 (d; J = 7.5 Hz; 3H; CH 3), 3.63 (q; J = 
7.5 Hz; 1H; CH; H-4), 3.97 (s; 6H; OCH 3), 5.33 (s; C H 2 ; H-l), 6.83 (s; 2H 
arom.). 
6,7-Dimethoxy-4-ethyl-isochroman-3-one (10b) 
From 9b; light-brown crystals, m.p. 84-85°C (EtOH).- C 1 3 H i 6 0 4 (236.3) 
Calc. C 66.1 H 6.83 Found C 65.7 H 6.84.- IR (KBr): 1740 (CO) cm'1.-
! H-NMR (CDCI3): 5 (ppm) = 1.07 (t; J = 7 Hz; 3H; CH 3), 1.77-2.17 (m; 
2H; CH2-CH3), 3.50 (t; J = 7 Hz; 1H; CH-CH 2 ; H-4), 3.93 (s; 6H; OCH 3), 
5.30 (d; J = 5 Hz; 2H; CH 2 ; H-l), 6.68,6.73 (s; 2H arom.). 
2-(3,4-Dimethoxyphenyl)propionic acid (9a) 
From 8a according to Jeffreysl9); yellow oil; lit. m.p. 50°C 1 9 ). 
2-(3,4-Dimethoxyphenyl)butyricacid (9b) 
From 8b according to Jeffreysl9); colorless crystals, m.p. 90-92°C (H 20); 
lit. 103°C2O). 
2-(3,4 -Dimethoxyphenyl)propionitrile (8a) 
Prepared from 3,4-dimethoxyphenylacetonitrile (Merck) according to 
ChavdarianX2) by the carboxylation procedure.- Colorless crystals; yield 
87%; m.p. 67-69°C (toluene), lit. 67-69°C1 2 ). 
2-(3,4-Dimethoxyphenyl)butyronitrile (8b) 
2.52 ml (18 mmole) of diisopropylamine are dissolved in 25 ml of absol. 
THF and cooled to -20°C. 7.74 ml of 2.3-molar n-BuLi (17.8 mmole) are 
added, the temp, should not exceed -10°C. Then the mixture is stirred for 
15 min at -20°C and cooled to -50°C. 16.9 mmole of 3,4-dimethoxyphenyl-
acetonitrile (Fa. Aldrich) in 10 ml of absol. THF are added below -40°C. 
After stirring for 5 min at -50°C, 1.45 ml (17.8 mmole) of C 2 H 5 I in 20 ml 
of absol. THF are added and the mixture is stirred again for 1 h at -60°C, 
then overnight at room temp, and poured on 50 ml of 2N HCl. The solution 
is extracted for a few times with ether, the org. layers are washed with 
H 2 0 , dried and evaporated.- Purification: CC (Si0 2, EtOAc), yield 80-
90%.- Colorless oil, b.p. 93-94°C, 0.1 T.-Lit. 2 0 ): m.p. 56-57°C- C 1 2 H 1 5 N 0 2 
(205.3) Calc. C 70.2 H 7.37 N 6.8 Found C 70.1 H 7.30 N 6.7.- IR (film): 
2260 (CN) cm'1.- J H-NMR (CDC13): 8 (ppm) = 1.03 (t; J = 7.5 Hz; 3H; 
CH 3), 1.93 (quin; J = 7.5 Hz; 2H; CH2-CH3), 3.63 (t; J = 7.5 Hz; 1H; 
CH-CH 2), 3.87 (s; 6H; OCH 3), 6.67-6.90 (m; 3H arom.). 
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